Bolt Biotherapeutics, Inc. Other Research and Development Expense
Bolt Biotherapeutics, Inc. (BOLT) reported Other Research and Development Expense of $793.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2026-08-11
- Bolt Biotherapeutics, Inc. other research and development expense for the quarter ending 2026-06-30 was $793.00K, a 41.56% decline year-over-year.
- Bolt Biotherapeutics, Inc. other research and development expense for the quarter ending 2025-06-30 was $1.36M.
| Period end | Other Research and Development Expense 3 month | Other Research and Development Expense 6 month |
|---|---|---|
| 2026-06-30 | $793.00K 10-Q · filed 2026-08-11 | $1.52M 10-Q · filed 2026-08-11 |
| 2025-06-30 | $1.36M 10-Q · filed 2026-08-11 | $4.17M 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |